|
Should experts with potential conflicts of interest be allowed to serve on FDA advisory panels?(Pro & Con)(Brief Article)
Publication: Skin & Allergy News Publication Date: 01-AUG-05 Author: Antony, Paul ; Furberg, Curt D.
|
|
|
|
How to access the full article: Free access to all articles is available courtesy of your local library. To access the full article click the "See the full article" button below. You will need your US library barcode or password.
|
|
|
COPYRIGHT 2005 International Medical News Group
[YES] What is the best thing for patients? That is the key question. Patients are best served when the experts who have the most knowledge about a medicine or disease advise officials at the Food and Drug Administration.
These individuals may receive funding from a variety of sources, from pharmaceutical companies to the National Institutes of Health to universities and foundations.
Legislation that might prevent the leading experts from advising the FDA because a portion of their funding comes from a particular source does not serve the interest of science or patients.
Certainly, however, the FDA and the public have a right to know about potential conflicts of interest.
The system...
Read the full article for free courtesy of your local library.
|
|
|
|
 |
| More Articles from Skin & Allergy News |
Congress negotiating error-reporting measure.(Practice Trends)(Brief A...
August 01, 2005
|
Sleep deprived? Tips to try for restful shut-eye.(The Rest of Your Lif...
August 01, 2005
|
Diagnosis: Churg-Strauss syndrome.(CASE OF THE MONTH)(Brief Article)
August 01, 2005
|
Enbrel indication is expanded.(Products)(Brief Article)
August 01, 2005
|
Anti-sebum gel fights facial shine.(Products)
August 01, 2005
|
|
| Find companies classified under Pharmaceutical preparations |
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
